Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Maryam Mukhamedova(National Institutes of Health), John R. Mascola(National Institute of Allergy and Infectious Diseases), LaSonji A. Holman(National Institutes of Health), Emily Phung(National Institutes of Health), Nancy J. Sullivan(National Institute of Allergy and Infectious Diseases), Pamela Costner(National Institutes of Health), Guillaume B. E. Stewart-Jones(Moderna Therapeutics (United States)), Barney S. Graham(National Institutes of Health), Alexandrine Derrien-Colemyn(National Institutes of Health), Daniel C. Douek(Institut de Recherche Vaccinale), Chaim A. Schramm(National Institutes of Health), Tracy J. Ruckwardt(National Institutes of Health), Somia P. Hickman(National Institutes of Health), Michelle C. Crank(National Institutes of Health), Peter D. Kwong(National Institutes of Health), Daniel Wrapp(Duke University), Kaitlyn M. Morabito(National Institutes of Health), Jason S. McLellan(The University of Texas at Austin), Lingshu Wang(National Institutes of Health), Martin R. Gaudinski(National Institute of Allergy and Infectious Diseases), Bharat Madan(University of Kansas), Scott A. Rush(The University of Texas at Austin), Lauren A. Chang(Icahn School of Medicine at Mount Sinai), Morgan S. A. Gilman(Harvard University), Brandon J. DeKosky(Ragon Institute of MGH, MIT and Harvard), Amy Ransier(National Institutes of Health), Chen‐Hsiang Shen(National Institutes of Health), Larissa Ault(National Institutes of Health), John Misasi(Boston University), Nicole A. Doria‐Rose(National Institutes of Health), Samuel Darko, Yi Zhang(National Institutes of Health), Grace Chen(Johns Hopkins University), Sarah Lucas(National Institutes of Health), Nina M. Berkowitz(National Institutes of Health)
Immunity
April 1, 2021
Cited by 71


Related Papers